Has David Swope, MD received payments from drug or device companies?

Yes. Drug and device makers reported $77,293 in general payments to David Swope, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Swope, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Swope, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Swope, MD

Neurology · New York, NYNPI 1538193800

Payments from drug & device makers

$77,293in general payments, 2019–2025

Across 15 payments — averaging $5152.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$52K
Biogen$21K
AbbVie$3K
Abbott$243
Boston Scientific$133
Acorda Therapeutics, Inc$107
plus $96 from 2 others

What the payments were for

Speaking & faculty fees$2,88082%
Food & beverage$61818%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	2	$52,492
Biogen	2	$21,303
AbbVie	2	$2,919
Abbott	3	$243
Boston Scientific	3	$133
Acorda Therapeutics, Inc	1	$107
Medtronic	1	$77
Sunovion Pharmaceuticals Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$77,293 in reported general payments places this provider in the 85th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Medicare billing

Part B allowed, 2024

$100,519

Medicare patients

386

Services billed

1,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tetrabenazine	14	$116,811
RytaryCarbidopa/Levodopa	92	$100,441
Rasagiline Mesylate	355	$53,633
Carbidopa-LevodopaCarbidopa/Levodopa	783	$27,401
Entacapone	58	$20,098
AmantadineAmantadine Hcl	178	$9,333
Primidone	223	$4,928
Pramipexole ErPramipexole Di-Hcl	28	$4,888
Zonisamide	139	$4,314
Donepezil Hcl	277	$2,498
Propranolol Hcl	111	$1,895
Midodrine Hcl	11	$1,606
Carbidopa-Levodopa ErCarbidopa/Levodopa	28	$1,557
Baclofen	43	$1,318
Selegiline Hcl	16	$966

Paid to pharmacies, not to this prescriber.

Other neurology in New York

Christian GrommesNew York$9.9M
Ilya KisterNew York$9.5M
E DorseyNew York$8.5M
Lauren SchaffNew York$8.2M
Martin SadowskiNew York$5.4M
Lawrence HonigNew York$4.9M
Sheng-Han KuoNew York$3.2M
Stephen KriegerNew York$3.1M
Thomas KaleyNew York$2.9M
Aaron MillerNew York$2.8M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →